Home/Filings/4/0001209191-20-059427
4//SEC Filing

Kouchakji Elias 4

Accession 0001209191-20-059427

CIK 0000921299other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:52 PM ET

Size

6.8 KB

Accession

0001209191-20-059427

Insider Transaction Report

Form 4
Period: 2020-11-17
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
  • Exercise/Conversion

    Common Stock

    2020-11-17$14.57/sh+7,082$103,220134,495 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-11-177,0820 total
    Exercise: $14.57Exp: 2024-03-19Common Stock (7,082 underlying)
Footnotes (1)
  • [F1]Fully vested.

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1
  • filerCIK 0001775259

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:52 PM ET
Size
6.8 KB